These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5671257)

  • 1. Synthesis and myotrophic-androgenic activity of substituted 2-alpha, 3-alpha-methano-5-alpha-androstane derivatives.
    Wolff ME; Cheng SY; Ho W
    J Med Chem; 1968 Jul; 11(4):864-8. PubMed ID: 5671257
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and myotrophic-androgenic activity of 17beta-hydroxy-5alpha-androst-8(14)-en-3-one derivatives.
    Wolff ME; Chang HH
    J Med Chem; 1970 Sep; 13(5):967-8. PubMed ID: 5458391
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
    Kasahara A; Onodera T; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
    [No Abstract]   [Full Text] [Related]  

  • 4. New classes of orally active hormonal derivatives. II. 17-Cycloalk-1'-enyl ethers of 17 -hydroxy-androstanes and 19-norandrostanes.
    Gardi R; Falconi G; Pedrali C; Vitali R; Ercoli A
    Steroids; 1972 May; 19(5):639-47. PubMed ID: 5041787
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterocyclic steroids. 4. Synthesis and androgenic activity of A-ring homosteroids.
    Zanati G; Wolff ME
    J Med Chem; 1972 Apr; 15(4):368-9. PubMed ID: 5019551
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative androgenic, myotrophic and antigonadotrophic properties of some anabolic steroids.
    Boris A; Stevenson RH; Trmal T
    Steroids; 1970 Jan; 15(1):61-71. PubMed ID: 5410669
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and anabolic/androgenic evaluation of novel 9alpha-fluorosteroids.
    Reyes-Moreno M; Ruiz-García JA; Ibarra-Reyes Y; Fuente-Hernández A; Vélez-Castro H; Hernández-Balmaseda I; Martínez-Hormaza I; Rodeiro-Guerra I; Ramírez JS; Reyes SM; Montiel-Smith S
    Eur J Med Chem; 2009 Nov; 44(11):4567-71. PubMed ID: 19615789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloprop(16 ,17 )androstanes.
    Fahrenholtz KE; Meyes KP; Kierstead RW
    J Med Chem; 1972 Oct; 15(10):1056-60. PubMed ID: 5069774
    [No Abstract]   [Full Text] [Related]  

  • 9. Anabolic-androgenic activity of A-ring modified androstane derivatives. I. A comparison of parenteral activity.
    Nutting EF; Klimstra PD; Counsell RE
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):627-34. PubMed ID: 6012541
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterocyclic steroids. 2. Synthesis and androgenic activity of A-ring oxaandrostanes.
    Zanati G; Wolff ME
    J Med Chem; 1971 Oct; 14(10):958-61. PubMed ID: 5115694
    [No Abstract]   [Full Text] [Related]  

  • 11. Anabolic agents. A-ring oxygenated androstane derivatives.
    Klimstra PD; Zigman R; Counsell RE
    J Med Chem; 1966 Nov; 9(6):924-9. PubMed ID: 5972054
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterocyclic steroids. 5. Sulfur, selenium, and tellurium 5alpha-androstane derivatives and their 7alpha-methylated congeners.
    Zanati G; Gaare G; Wolff ME
    J Med Chem; 1974 May; 17(5):561-3. PubMed ID: 4830264
    [No Abstract]   [Full Text] [Related]  

  • 13. Anabolic-androgenic activity of A-ring modified androstane derivatives. II. A comparison of oral activity.
    Nutting EF; Klimstra PD; Counsell RE
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):635-43. PubMed ID: 5953689
    [No Abstract]   [Full Text] [Related]  

  • 14. The causes of the prolonged action of 5-alpha-androst-2-EN-17-beta-OL.
    Cekan Z; Bartosek I
    Steroids; 1967 Jul; 10(1):75-81. PubMed ID: 6059114
    [No Abstract]   [Full Text] [Related]  

  • 15. The growth of the ventral prostate, the dorsolateral prostate, the coagulating glands and the seminal vesicles in castrated male rats injected with ACTH and-or insulin.
    Tisell LE; Angervall L
    Acta Endocrinol (Copenh); 1969 Dec; 62(4):694-710. PubMed ID: 4311984
    [No Abstract]   [Full Text] [Related]  

  • 16. Anabolic agents. 2,3-Epithioandrostane derivatives.
    Klimstra PD; Nutting EF; Counsell RE
    J Med Chem; 1966 Sep; 9(5):693-7. PubMed ID: 5969041
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroids. XXX. Some indolocholestanes and indoloandrostanes.
    Doorenbos NJ; Wu MT
    J Med Chem; 1968 Jan; 11(1):158-9. PubMed ID: 4966060
    [No Abstract]   [Full Text] [Related]  

  • 18. Thia steroids. I. 2-Thia-A-nor-5-alpha-androstan-17-beta-ol, an active androgen.
    Wolff ME; Zanati G
    J Med Chem; 1969 Jul; 12(4):629-31. PubMed ID: 5793153
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and mode of action of androgens in target tissue of male rats. IV. Mode of action of 5 alpha-androstane-3,17-dione, 5 alpha-androstane-3 alpha,17 beta-diol and of 5 alpha-androstane-3 beta,17 beta-diol at a cellular level on seminal vesicles and prostates of rats.
    Schmidt H; Giba-Tziampiri O; von Rotteck G; Voigt KD
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):599-611. PubMed ID: 4740851
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
    Ahmad N; Warren DW; Haltmeyer GC
    Anat Rec; 1978 Dec; 192(4):543-54. PubMed ID: 736274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.